An 18-year-old woman died at Genoa's
San Martino hospital on Thursday after suffering a blood clot
following vaccination with the AstraZeneca jab on May 25.
A causal link between the death of Camilla Canepa and the
vaccination has not been established, however.
Canepa, who was from the town of Sestri Levante in Liguria, was
given the jab during a vaccination 'open day' for over 18s.
The case has raised concerns about the use of the AstraZeneca
vaccine on young people.
The AstraZeneca jab has been approved for all over-18s, but in
Italy it is only recommended for over-60s due to links to rare
cases of blood clots in younger people.
This, however, is not an outright ban and the AstraZeneca jab is
widely being used in Italy for under-60s, especially since the
government made it possible for all adult age groups to book
vaccinations, not just the oldest and people considered
vulnerable.
The question has come to the fore with many young people keen to
get vaccinated on a voluntary basis to obtain the Green Pass
enabling them to travel and attend certain events.
Liguria Governor Giovanni Toti said Friday that Canepa's case
should not be used for point scoring, stressing that that "the
option of using AstraZeneca for everyone on a voluntary basis
was not invented by the regional governments or by a Dr
Strangelove, it was suggested by the top technical-scientific
bodies in order to increase vaccinations and, therefore, prevent
deaths".
ALL RIGHTS RESERVED © Copyright ANSA
